Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

jakob-riis

Novo pledges single-digit cap on drug price hikes

December 7, 2016 Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk

Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …
News

Pfizer slapped with record £84.2 million fine for 2,600% price increase

December 7, 2016 Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine

Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
News
astrazeneca_sign_sky

AZ lung cancer drug cuts disease progression by 70%

December 7, 2016 Research and Development AstraZeneca, Tagrisso

AstraZeneca is touting its cancer drug Tagrisso (osimertinib) as a potential new standard of care for epidermal growth factor receptor …
News
shire_image

Shire given permission for $400 million biologics manufacturing facility

December 6, 2016 Manufacturing and Production, Research and Development Co Meat, Ireland, Shire

Shire has received planning permission for a new state-of-the-art biologics manufacturing facility in Co Meath, Ireland. The plant will be …
News
jake_dupont

CMO of OncoMed Pharma resigns

December 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …
Appointment
sigurdur_olaffson_teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
Appointment
gwpharma

Cannabis-based treatment scores Phase 3 successes for GW Pharma

December 6, 2016 Manufacturing and Production, Research and Development GW Pharma, cannabidiol

UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …
News
jeffrey_eisenberg

Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic

Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …
Appointment

Mission Therapeutics announces new non-executive chairman

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment

Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …
Appointment
hands-coffee-smartphone-technology_smaller

Technology and patient adherence: Putting control of medication directly in patients’ hands

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing apps, patient adherence, technology

Ben Hargreaves looks at how apps and medical devices could reduce these figures by providing patients new ways of keeping …
Feature
reneuron

ReNeuron’s stem cell therapy improves motor function in stroke study

December 5, 2016 Research and Development ReNeuron, stem cell, stem cell therapy, stroke

ReNeuron, a UK-based biotechnology company, posted results of its experimental stem cell therapy for patients who had been disabled after …
News
161201120435_1_900x600

New molecular-binding technique promises accelerated drug development

December 5, 2016 Research and Development, Sales and Marketing Alzheimer's, Cancer, Indiana University-Purdue University Indianapolis

Researchers at the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) have claimed to have designed a new molecular …
News
novartis_building

Novartis posts 82% remission rate in CAR T paediatric study

December 5, 2016 Research and Development, Sales and Marketing CAR T, CAR-T, Novartis, leukaemia, paediatric

Novartis has released the results of its global, paediatric study of the treatment of leukaemia in children and young adults …
News
kitepharma_fullcolor_rgb

Kite Pharma names new senior VP of Supply Chain

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, kite pharma

Santa-Monica-based clinical-stage biopharmaceutical firm Kite Pharma has appointed Dr Jian Irish as senior vice president of Supply Chain, who will …
Appointment
eisai_halaven_eribulin_web

Eisai & Clinigen to bring breast cancer drug to South Africa

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer

Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026